![](/img/cover-not-exists.png)
Development of AO-176, a Next Generation Humanized Anti-CD47 Antibody With Novel Anti-Cancer Properties and Negligible Red Blood Cell Binding
Puro, Robyn J, Bouchlaka, Myriam N, Hiebsch, Ronald R, Capoccia, Benjamin J, Donio, Michael J, Manning, Pamela T, Frazier, William A, Karr, Robert W, Pereira, Daniel SLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-19-1079
Date:
December, 2019
File:
PDF, 5.18 MB
english, 2019